Literature DB >> 12809814

Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?

Andy S Yu, Emmet B Keeffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12809814     DOI： 10.1111/j.1572-0241.2003.07485.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  20 in total

1.  Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline.

Authors:  Zhaohui Cai; Anastasia M Christianson; Lars Ståhle; Marianne Keisu
Journal:  Eur J Clin Pharmacol       Date:  2009-06-25       Impact factor: 2.953

2.  Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats.

Authors:  Jesudoss Victor Antony Santiago; Jayaraman Jayachitra; Madhavan Shenbagam; Namasivayam Nalini
Journal:  Eur J Nutr       Date:  2011-03-29       Impact factor: 5.614

3.  Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Sarah A Aroner; Kenneth J Mukamal; David E St-Jules; Matthew J Budoff; Ronit Katz; Michael H Criqui; Matthew A Allison; Ian H de Boer; David S Siscovick; Joachim H Ix; Majken K Jensen
Journal:  Am J Epidemiol       Date:  2016-11-17       Impact factor: 4.897

4.  Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors.

Authors:  Wing-Kin Syn; Peter Nightingale; Jeffrey M Bateman
Journal:  Hepatol Int       Date:  2008-02-28       Impact factor: 6.047

5.  Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

Authors:  Winston Dunn; Ronghui Xu; Deborah L Wingard; Christopher Rogers; Paul Angulo; Zobair M Younossi; Jeffrey B Schwimmer
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

6.  Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos.

Authors:  Jun Li; Simin Hua; Guo-Chong Chen; Garrett Strizich; Mark H Kuniholm; Zhilei Shan; Gregory A Talavera; Sheila F Castañeda; Marc D Gellman; Jianwen Cai; Scott J Cotler; Xuehong Zhang; Frank B Hu; Robert Kaplan; Carmen R Isasi; Qibin Qi
Journal:  Liver Int       Date:  2020-05-25       Impact factor: 5.828

7.  Prediction of liver injury using the BP-ANN model with metabolic parameters in overweight and obese Chinese subjects.

Authors:  Lufeng Hu; Fan Wang; Jinzhong Xu; Xiaofang Wang; Hong Lin; Yi Zhang; Yang Yu; Youpei Wang; Lingxia Pang; Xi Zhang; Qi Liu; Guoshi Qiu; Yongsheng Jiang; Longteng Xie; Yanlong Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.

Authors:  Hyunghee Lee; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Int J Obes (Lond)       Date:  2018-10-03       Impact factor: 5.095

9.  Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.

Authors:  S Kechagias; A Ernersson; O Dahlqvist; P Lundberg; T Lindström; F H Nystrom
Journal:  Gut       Date:  2008-02-14       Impact factor: 23.059

10.  Evaluation of the effects of hydroalcoholic extract of Berberis vulgaris root on the activity of liver enzymes in male hypercholesterolemic rats.

Authors:  Soheila Taheri; Ali Zarei; Saeed Changizi Ashtiyani; Azam Rezaei; Saeed Zaheiri
Journal:  Avicenna J Phytomed       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.